S5 Ep28: Musician Andrew McMahon on Setlists, Surfing and Surviving Cancer
Cancer Horizons7 Syys 2023

S5 Ep28: Musician Andrew McMahon on Setlists, Surfing and Surviving Cancer

For Andrew McMahon, a singer-songwriter and cancer survivor, the act of forgetting an anniversary was a good thing.

Alongside his band, Andrew McMahon and the Wilderness, he was set to play the inaugural Adjacent festival on the beach in Atlantic City, New Jersey on May 27, part of a daily lineup that included Paramore, Jimmy Eat World and Bleachers.

The date of the festival coincided with a landmark moment in his cancer journey, which began in 2005. Before the end of a tour as part of Jack’s Mannequin, he received a diagnosis of acute lymphoblastic leukemia (ALL), for which he eventually underwent treatment with chemotherapy, radiation and a stem cell transplant.

“About an hour and a half before the show, I'm working on the setlist,” McMahon told CURE®. “And every day, I do the setlist and then at the top of the setlist I put the city and the date. And I asked somebody, like, ‘What's the date today?’ And they said, ‘It's the 27th,’ then as I'm typing the date, I realize, ‘Oh, that's the anniversary of when I was put in the hospital.’

“And we were in Atlantic City, and I had been between New Jersey and New York when I did the initial blood work that ended up leading to my hospitalization and eventually my diagnosis. Historically, that has been a very fraught anniversary for me. In the early years … even when I wouldn't realize the anniversary was coming up that weekend, inevitably, I was a mess. … So, being in a place now where I can actually forget those anniversaries, like they can almost pass me by and there's no trigger there, I'm on a healthy footing and that's pretty miraculous.”

McMahon founded the Dear Jack Foundation in 2006. The organization supports young adult cancer patients and survivors “through programs that provide support and community to a demographic far too often forgotten,” according to the Dear Jack Foundation website.

In this episode of the “Cancer Horizons” podcast, McMahon speaks with CURE® about life nearly 20 years after receiving his cancer diagnosis, shares the advice he has for patients who have recently received a diagnosis of their own and discusses his newfound love of surfing.

“The beauty of surfing is that you just have to you take what you get, right? A lot of it is about learning how to understand what the natural environment around you is doing and then using that to get yourself into just about the greatest feeling that you can have on Earth, which is riding a wave,” McMahon said. “And so, I think it's been very good for me in the sense that it has really hammered home how valuable and how important it is to commune with the natural world.

“And it's also one of just the very few spaces I can think of where whatever's happening in my life and whatever's going on in my business, or things that I might be worried about or afraid of, or whatever, I just don't carry those things into the water with me. And it's not really a conscious thing. It's just once I'm there, you're just present. And I definitely, at this stage of my life — I've always been pretty good about keeping the phone at bay, and I'm not a huge social media guy, I'm not so plugged in, but I'm way more plugged in than I have ever been in my life — having a space where nobody can reach me and I can just do something that so akin to just play playing, I think as adults we don't play as much as we ought to is really good for the brain and I've found a lot of peace in the water for sure.”


For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.



Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(295)

S7 Ep2: Breaking Down Metastatic Triple-Negative Breast Cancer Treatments

S7 Ep2: Breaking Down Metastatic Triple-Negative Breast Cancer Treatments

CURE sat down with Dr. Natalie S. Berger for the latest episode of the “Cancer Horizons” podcast to discuss frontline treatment options for patients with metastatic triple-negative breast cancer. Berg...

31 Joulu 202514min

S7 Ep1: The Importance of Spotting Endometrial Cancer

S7 Ep1: The Importance of Spotting Endometrial Cancer

Endometrial cancer is on the rise. Hear survivor Angélica and Eisai Inc.'s Teresa Cronin discuss the Spot Her® initiative, which empowers women to spot early signs. This episode is sponsored by Eisai.

18 Maalis 202510min

S6 Ep23: ROS1+ Non-Small Cell Lung Cancer: Progress in Care

S6 Ep23: ROS1+ Non-Small Cell Lung Cancer: Progress in Care

17 Syys 202419min

S6 Ep22: Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

S6 Ep22: Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma. And finally, we’ll discuss another ca...

4 Maalis 20247min

S6 Ep21: Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

S6 Ep21: Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, an...

4 Maalis 202410min

S6 Ep20: FDA Approvals from February 2024

S6 Ep20: FDA Approvals from February 2024

Last week, the Food and Drug Administration (FDA) approved four different therapies in the oncology space — one of which, Amtagvi, marks the first cellular therapy for the treatment of solid cancers. ...

23 Helmi 20246min

S6 Ep19: Pancreatic Cancer Approval, Expert Discussion on Cancer Vaccine Development

S6 Ep19: Pancreatic Cancer Approval, Expert Discussion on Cancer Vaccine Development

Last week, we saw some FDA approvals for a new drug regimens, as well as some expert opinion about cancer vaccines. Additionally research touched upon the potential benefit of concurrent ctDNA and tum...

19 Helmi 20249min

S6 Ep18: Guidelines for Childhood Neuroblastoma, FDA Decisions and More

S6 Ep18: Guidelines for Childhood Neuroblastoma, FDA Decisions and More

Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews. Also last week, we covered researc...

12 Helmi 20247min

Suosittua kategoriassa Tiede

rss-mita-tulisi-tietaa
rss-hereilla
rss-poliisin-mieli
tiedekulma-podcast
rss-duodecim-lehti
docemilia
hippokrateen-vastaanotolla
radio-antro
filocast-filosofian-perusteet
rss-ilmasto-kriisissa
rss-opeklubi
rss-kasvikutsut